Keywords: intermune, completes, enrollment, ph, iii, actimmune, trial

InterMune completes enrollment in Ph III Actimmune trial

Article | 24 April 2006

US drugmaker InterMune has completed patient enrollment in the INSPIRE trial, a pivotal Phase III clinical evaluation of Actimmune (interferon ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Actimmune

Interferon Gamma 1 b

Go to drug listing